Skip to main content
Log in

Evidence of nucleos(t)ide analogue (NUC) therapy in HBV DNA negative decompensated cirrhosis

  • Letter to the Editor
  • Published:
Hepatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Singal AK, Fontana RJ. Meta-analysis: Oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis. Aliment Pharmacol Ther. 2012;35(6):674–89.

    Article  CAS  Google Scholar 

  2. Peng CY, Chien RN, Liaw YF. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. J Hepatol. 2012;57(2):442–50. https://doi.org/10.1016/j.jhep.2012.02.033.

    Article  CAS  PubMed  Google Scholar 

  3. Das K, Das K, Datta S, Pal S, Hembram JR, Dhali GK, et al. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis. Liver Int. 2010;30(7):1033–42.

    Article  Google Scholar 

  4. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98.

    Article  CAS  Google Scholar 

  5. Tavis JE, Gehring AJ, Hu Y. How further suppression of virus replication could improve current HBV treatment. Expert Rev Anti Infect Ther. 2013;11(8):755–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahinul Alam.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alam, S., Khan, M.A.S. & Khan, M. Evidence of nucleos(t)ide analogue (NUC) therapy in HBV DNA negative decompensated cirrhosis. Hepatol Int 15, 1028–1029 (2021). https://doi.org/10.1007/s12072-021-10225-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-021-10225-3

Navigation